 Patients: early less than 6 months, active DAS5.2,potentially severe Leiden score6 Study design:12 months, prospective , randomized, open Study treatments: Methotrexate at a weekly dose of 0.3mgkilo alone or in combination with adalimumab 40 mg every the other week Outcome measures: DAS over the 12 months 